He received his B.A. in Human Biology at Stanford University and his Ph.D. in Organismal and Evolutionary Biology at Harvard University. Dr. Dorit's lab is broadly concerned with experimental, retrospective and computational approaches to molecular evolution. His group addresses resistance in antimicrobial design, which employs in vitro engineering approaches and large-scale screening to engineer antimicrobial toxins for use against enteric pathogens. He also studies in vivo experimental evolution by "re-evolving" RNase P RNA. Finally, Dr. Dorit is investigating the genetic dynamics of the seed bank in a weed species, Stellaria media. Dr. Dorit is a founder and CEO of Origin Antimicrobials LLC, a biopharmacuetical start-up company focused on generating novel antimicrobials.